Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease.
暂无分享,去创建一个
F. Violi | A. D’Angelo | L. Loffredo | F. Fimognari | S. Di Simone | S. Simone | F. Sampietro | R. Pastorelli | M. Monaldo
[1] D. Sin,et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[2] S. Scarlata,et al. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease , 2008, International journal of chronic obstructive pulmonary disease.
[3] T. Seemungal,et al. Plasma homocysteine is elevated in COPD patients and is related to COPD severity , 2007, International journal of chronic obstructive pulmonary disease.
[4] Xiping Xu,et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis , 2007, The Lancet.
[5] F. Rutten,et al. Heart failure and chronic obstructive pulmonary disease: An ignored combination? , 2006, European journal of heart failure.
[6] S. Yusuf,et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.
[7] Per Magne Ueland,et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.
[8] K. Sekizawa,et al. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese. , 2006, Archives of gerontology and geriatrics.
[9] B-Vitamin Treatment Trialists. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. , 2006, American heart journal.
[10] S. Scarlata,et al. Restrictive ventilatory dysfunction and dyspnea in elderly subjects. , 2005, The American journal of medicine.
[11] R. Roubenoff,et al. Inflammation causes tissue-specific depletion of vitamin B6 , 2005, Arthritis research & therapy.
[12] D. Sin,et al. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. , 2005, Chest.
[13] A. Schols. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management , 2003, European Respiratory Journal.
[14] Ben-Ami Sela,et al. Hyperhomocysteinemia as a component of syndrome X. , 2003, Metabolism: clinical and experimental.
[15] A. Folsom,et al. B vitamin status and inflammatory markers. , 2003, Atherosclerosis.
[16] R. Clarke,et al. Screening for vitamin B-12 and folate deficiency in older persons. , 2003, The American journal of clinical nutrition.
[17] Don D. Sin,et al. Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease , 2003 .
[18] W. Ageno,et al. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. , 2003, Thrombosis research.
[19] P. Galan,et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. , 2002, The American journal of clinical nutrition.
[20] Per Magne Ueland,et al. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.
[21] B. Hedblad,et al. Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function: A Study From “Men Born in 1914,” Malmö, Sweden , 2001, Circulation.
[22] K. Larsson,et al. Hyperhomocysteinemia and Changed Plasma Thiol Redox Status in Chronic Obstructive Pulmonary Disease , 2001, Clinical chemistry and laboratory medicine.
[23] A. Arboix,et al. Different vascular risk factor profiles in ischemic stroke subtypes: a study fromthe “Sagrat Cor Hospital of Barcelona Stroke Registry” , 2000, Acta neurologica Scandinavica.
[24] R. Rodríguez-Roisín,et al. Toward a consensus definition for COPD exacerbations. , 2000, Chest.
[25] R. Paroni,et al. High-performance liquid chromatographic method for measuring total plasma homocysteine levels. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[26] J. Selhub,et al. Homocysteine and thrombotic disease. , 1997, Blood.
[27] E. Vartiainen,et al. Symptoms of chronic bronchitis and the risk of coronary disease , 1996, The Lancet.
[28] Vernon,et al. Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate. , 1983, Clinical chemistry.
[29] J Froom,et al. The International Classification of Health Problems for Primary Care. , 1975, Medical care.
[30] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .